Within the 17 Sustainable Development Goals (SDGs) a total of 169 targets and over 230 indicators have been defined \[[@R1]\]. In alignment with the SDGs, the Global Strategy for Women's, Children's and Adolescents' Health (the Global Strategy) has described an ambitious action and measurement agenda around the three pillars "Survive, Thrive and Transform" \[[@R2]\]. In the immediate future many countries have an unfinished agenda to accelerate the scale--up of cost--effective essential maternal, newborn and child health (MNCH) interventions that save lives as well as help families to thrive \[[@R3]\]. Tracking intervention coverage is a top priority to assist this scale--up so that countries know the extent to which populations in need are benefiting, and delivery strategies are refined as a result \[[@R4]\]. In this paper we examine priorities in coverage measurement of essential MNCH interventions, distinguishing between those that can be measured now and those that require methodological development.

Of particular importance is to explicitly acknowledge known measurement challenges across the continuum from pregnancy to childhood \[[@R5]--[@R7]\], and categorise indicators that can be measured now using existing methods and tools ("*indicators for immediate use*"), and those that are high priority in the context of life--saving, quality care but require further methodological development and validation ("*priority indicators for development"*). Once validated using feasible methods, these priority indicators for development can be further described in global guidance and integrated within existing data collection systems.

The remainder of this paper proposes a transparent set of evidence--based considerations for the global MNCH measurement improvement agenda. We draw on evidence supporting cost--effective investments in MNCH \[[@R3]\], recommendations by the Global Strategy \[[@R8]\], and the priorities identified by other initiatives including the Global Reference List of 100 core indicators \[[@R9]\], the World Health Organization's consultation on quality MNCH \[[@R10]\], the Every Newborn Action Plan (ENAP) \[[@R11]\], and Ending Preventable Maternal Mortality (EPMM) \[[@R12]\].

METHODS AND CONSIDERATIONS IN SELECTING INDICATORS FOR IMMEDIATE USE
====================================================================

[**Figure 1**](#F1){ref-type="fig"} presents a typology of indicators related to intervention coverage. Level A encompasses all women and children who can benefit from receiving care, including preventive and curative services.  From this group, only some will access care and have the opportunity to benefit from the services they need (level B). But making contact with services does not ensure receipt of a specific intervention (level C), irrespective of whether the population making contact needs a preventive or curative intervention. Currently, coverage measurement for any given intervention is defined as C/A, or the proportion of women and children who need an intervention who actually receive it. The innermost element of the framework (level D) highlights the importance of incorporating dimensions of quality within coverage, often referred to as "effective coverage", for example including measures of appropriate diagnosis, drug dosage, or counselling.  The need for development of globally standardised measures of effective coverage is described in more detail below.
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Our considerations for determining the measurement status of indicators builds on the experience and evidence base generated by others, including household survey programs such as Demographic and Health Surveys (DHS) \[[@R13]\] and the Multiple Indicator Cluster Surveys (MICS) \[[@R14]\], the Countdown to 2015 for Maternal, Newborn and Child Survival (Countdown) initiative \[[@R15]\], and the investment and visibility promoted by the Commission on Information and Accountability for Women's and Children's Health (CoIA) and its independent Expert Review Group (iERG) \[[@R16]\].

We took five characteristics into account in selecting priority indicators.

1\) **Public health importance**. Priority indicators should measure progress in coverage for an intervention that has the potential to save a large number of women's and children's lives, because it is linked through known channels to changes in health status. We estimate this potential using the Lives Saved Tool (LiST) \[[@R17]\], calculating the number of maternal, newborn and child lives that could be saved by 2030 based on the underlying assumptions within the model, and if universal coverage was achieved for the intervention in the 75 countries that accounted for 99% of deaths among those groups in 2014, assuming coverage trajectories for all other interventions remain the same ([**Table 1**](#T1){ref-type="table"}). We have included indicators for malaria and HIV because of their importance in some high burden countries, even though they do not account for large numbers of deaths in all countries.

###### 

LiST analysis of lives saved by labor and delivery management, and life--saving interventions for mothers, newborns and children\*

                                                                                                      Estimated number of deaths averted                                                         
  --------------------------------------------------------------------------------------------------- ------------------------------------ -------------- ----------- -------------- ----------- ----------
  **Intervention**                                                                                    **Stillbirths**                      **Neonatal**   **Child**   **Maternal**   **Total**   **Rank**
  Labor & delivery management                                                                         689 758                              549 031                    76 850         1 315 639   1
  Full supportive care for prematurity                                                                                                     544 458                                   544 458     2
  Full supportive care for sepsis/pneumonia                                                                                                409 877                                   409 877     3
  Oral Rehydration Solution                                                                                                                12 653         369 423                    382 076     4
  Water connection in the home                                                                                                                            368 313                    368 313     5
  Treatment with antimalarials                                                                                                                            303 653                    303 653     6
  Oral antibiotics for pneumonia                                                                                                                          300 682                    300 682     7
  Promotion of breastfeeding                                                                                                               74 699         191 976                    266 675     8
  Hand washing with soap                                                                                                                                  235 898                    235 898     9
  Neonatal resuscitation                                                                                                                   212 439                                   212 439     10
  Therapeutic feeding for severe wasting                                                                                                                  209 442                    209 442     11
  Injectable antibiotics for neonatal sepsis/pneumonia                                                                                     181 512                                   181 512     12
  Kangaroo Mother Care                                                                                                                     158 853                                   158 853     13
  Syphilis detection and treatment                                                                    149 597                              7 060                                     156 657     14
  Pneumococcal vaccine                                                                                                                                    139 779                    139 779     15
  Improved sanitation                                                                                                                                     136 256                    136 256     16
  Clean postnatal practices                                                                                                                131 782                                   131 782     17
  Clean birth practices                                                                                                                    101 266                    20 148         121 414     18
  Treatment for moderate acute nutrition of children                                                                                                      110 671                    110 671     19
  Immediate assessment and stimulation of newborns                                                                                         109 585                                   109 585     20
  Hib vaccination                                                                                                                                         106 998                    106 998     21
  Zinc--for treatment of diarrhea                                                                                                                         106 481                    106 481     22
  Zinc supplementation                                                                                                                                    104 426                    104 426     23
  Magnesium sulphate for pre--eclampsia                                                               64 939                                                          23 681         88 620      24
  Homes protected from malaria by ownership of insecticide treated nets or indoor residual spraying                                                       87 733                     87 733      25
  Chlorhexidine for cord care                                                                                                              82 283                                    82 283      26
  Appropriate complementary feeding                                                                                                                       80 081                     80 081      27
  Intermittent presumptive treatment for malaria in pregnancy                                         59 942                               16 111         1 539       1 404          78 996      28
  Oral antibiotics for neonatal sepsis or pneumonia                                                                                        74 462                                    74 462      29
  Thermal care for newborns                                                                                                                72 391                                    72 391      30
  Hygienic disposal of stools                                                                                                                             64 653                     64 653      31
  Periconceptual Folic Acid / Ferrous Sulfate                                                         17 711                               43 296                                    61 007      32
  Antibiotics for premature preterm rupture of membranes                                                                                   49 257                     7 903          57 160      33
  Rotavirus vaccine                                                                                                                                       56 788                     56 788      34
  Induction of labor for pregnancies beyond 42 weeks                                                  47 230                                                                         47 230      35
  Balanced energy protein supplementation for pregnant women                                                                               41 268         3309                       44 577      36
  Multiple micronutrients for pregnant women                                                                                               39 615         2788                       42 403      37
  Active management of third stage of labor                                                                                                                           33 782         33 782      38
  Case management of maternal sepsis                                                                                                                                  23 528         23 528      39
  Iron supplementation for pregnant women                                                                                                  21 964         1555                       23 519      40
  Diabetes case management for pregnant women                                                         22 585                                                                         22 585      41
  Magnesium sulfate for treatment of eclampsia                                                                                                                        22 572         22 572      42
  Improved water                                                                                                                                          21 470                     21 470      43
  Case management of hypertensive disorders in pregnant women                                                                                                         20 025         20 025      44
  Safe abortion services                                                                                                                                              15 529         15 529      45
  DPT3 vaccination                                                                                                                                        15 428                     15 428      46
  Tetanus toxoid vaccination                                                                                                               14 940                     161            15 101      47
  Vitamin A supplementation                                                                                                                               14 967                     14 967      48
  Vitamin A--for treatment of measles                                                                                                                     14 574                     14 574      49
  Post abortion case management                                                                                                                                       13 391         13 391      50
  Calcium supplementation                                                                                                                                             8124           8124        51
  Ectopic pregnancy case management                                                                                                                                   2980           2980        52
  Case management of malaria in pregnant women                                                                                                                        2347           2347        53
  Antibiotics for dysentery                                                                                                                               1017                       1017        54

Hib -- *Haemophilus influenzae* type B, DPT3 -- diphtheria--tetanus--pertussis

**\***The potential number of lives saved by 54 evidence based interventions by 2030, estimated using the Lives Saved Tool if universal coverage was achieved for each intervention in the 75 countries that accounted for 99% of maternal, newborn and child deaths in 2014, assuming coverage trajectories for all other interventions remain the same.

2\) **Feasibility and affordability**. Indicators for immediate use must be affordable and feasible for accurate measurement in the majority of high--MNCH mortality countries to inform immediate actions.  But high--impact interventions for which feasible and cost--effective measurement strategies are not currently available must not be lost and are the target of an urgent developmental research agenda, described below under *priority indicators for development*.

3\) **Accuracy.** Measurement approaches that do not produce valid results are a waste of scarce resources, and can misdirect policy and program decisions. There is a growing body of research demonstrating that mothers interviewed during household surveys (as in DHS or MICS) can report accurately on whether they and their children received some interventions, but not others.  Particularly problematic are high impact interventions around the time of birth and curative interventions for episodes of illness such as antibiotics for pneumonia \[[@R18]--[@R20]\]. New and innovative approaches for measuring coverage for these interventions are needed urgently, while maintaining support for household surveys able to produce highly--accurate estimates of coverage for most MNCH interventions. Surveys are also essential for assessing equity through disaggregated analyses, as required by SDG target 17.18 on the measurement of inequalities.

4\) **Production of timely results with clear action implications.** Indicator levels should change in response to increases or decreases in program inputs and outputs and improvements in program processes, within a time frame of one to three years, to provide information useful to program managers. Experience has demonstrated that monitoring systems work best and are more likely to be sustained if the data they contain are used first at the level at which they are collected, and also at each higher level throughout the reporting system. Of importance is to encourage reporting and use of individual indicator components from the point of data collection through national level, but combining the components for global monitoring.

5\) **Consistency with historical indicators, to permit tracking of trends.** Lists of indicators evolve over time. New interventions are scaled up that require new indicators, but also the validity of existing indicators may be challenged by new evidence. For example, the indicator for diarrhea management used in most surveys since the 1990s was oral rehydration therapy (ORT), but more recently there has been a shift towards reporting on oral rehydration salts (ORS) plus zinc \[[@R21]\]. For the purpose of assessing time trends as we transition from the Millennium Development Goals (MDGs) to the SDGs it is useful to continue to report on ORT as well as ORS for a period of time, while also designing measurement methods so that adjustments to indicator definition can be made.

GETTING STARTED: INDICATORS FOR IMMEDIATE USE
=============================================

In [**Figure 2**](#F2){ref-type="fig"} we present the contacts and interventions prioritized by different global groups in MNCH (for example ENAP, EPMM, the Global Strategy), and include those supported by evidence of impact from LiST analysis ([**Table 1**](#T1){ref-type="table"}). After consideration of the five characteristics above these have been categorized as "*current*" or "*priority for development*".
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Contacts are included in order to measure the proportion of individuals accessing care, and thus potential to receive interventions, corresponding to level B in [**Figure 1**](#F1){ref-type="fig"}. In addition to the contacts for antenatal care, skilled attendant at birth, and postnatal care, we also include care seeking for sick children (specifically fever and symptoms of childhood pneumonia), consistent with the typology that distinguishes accessing care from actual receipt of a life--saving intervention. Correct treatment of these two conditions are among the highest--impact interventions, but cannot be measured accurately through household surveys. We also indicate the need to develop, agree on and validate indicators that reflect quality care at these contact points to enable tracking of effective coverage measures \[[@R22]\]. The remainder of [**Figure 2**](#F2){ref-type="fig"} presents intervention indicators. High impact interventions are represented across the continuum from pregnancy to childhood and measurement development needs are identified at each stage. Addressing these needs requires immediate action, as described in the next section.

DOING BETTER: AN ACTION AGENDA FOR IMPROVED MEASUREMENT
=======================================================

Priority indicators for development predominate around interventions at the time of birth, interventions to treat infections, and quality of care. Some of these represent relatively rare events (for example antibiotics for preterm premature rupture of membranes) and may never be suitable for population level tracking at national level, but nonetheless require advances in measurement in order to report accurately to country programs. For many, service contact indicators have been used to represent imperfect proxy measures of care but the need for measures of quality care means that we have to do better.   For example, the service contact indicator "skilled attendant at birth" is the most widely used proxy indicator for care at birth, but the evidence linking increases in skilled attendant coverage with reductions in mortality has not been consistent \[[@R23]--[@R25]\], probably reflecting the fact that only a subset of locally--defined skilled attendants actually have the skills, commodities and facilities needed to deliver essential interventions at birth.

We propose that four specific types of measurement innovations are required.

First, a measurement improvement agenda is needed for routine data capture, so that the accuracy of reporting clinical interventions for women, newborns and children is improved at different levels of the health system. This will allow delivery of high impact interventions to be tracked at local, national and global levels. It will require improved routine data systems, review and consolidation of facility assessment tools and methods, and engagement with health system strengthening efforts more broadly.

Second, to realize the potential of these improved data sources, methods for linking population and provider--based data sources are needed \[[@R5],[@R17]\]. Household survey methods provide population level data and permit equity analysis but can be limited by poor recall and infrequent reporting. Facility data can be continuous and timely, has potential to improve reporting on clinical events, and can be stratified by level and type. However, present reporting tools cannot provide accurate equity breakdowns or population level estimates. Combining these two data streams has the potential to be transformative for monitoring the delivery of essential interventions that cannot currently be measured reliably, and for measuring effective coverage so that coverage indicators are defined as level D/A in [**Figure 1**](#F1){ref-type="fig"}.

Third, further advances in implementation science are needed in order to place indicator development in the context of research on the design, implementation and impact of large scale programs.

And fourth, as new measures and approaches are tested and proven ready for wider adoption, global resources and guidance should be developed. Resources would include access to questionnaires, forms, and protocols; perhaps in one accessible system. Global guidance would include definitions, strengths and limitations of potential data sources, and interpretation notes.

TAKING THE AGENDA FORWARD
=========================

This paper adds to other recent calls for improved measurement that can enhance accountability and refine strategies to save lives \[[@R26]\]. At this time of transition from the MDGs to the SDGs it is essential that baselines are established, ambition is maintained, guidance and resources are shared, and momentum is not lost. Clarity about which essential interventions can be measured directly, reliably and feasibly using existing methods is an integral part of that plan. But here we also identify the need for focused, intensive commitment to advance the coverage measurement agenda for all essential interventions--especially those that save lives during and immediately after childbirth, and for sick children--so that we progress from reliance on measuring contacts with health care providers to measuring the effective coverage of clinical high--impact interventions.

As we enter the SDG era, several key partners are stepping forward to join this global measurement agenda for maternal, newborn and child health to agree on priorities, to coordinate actions and learning, and to work together with countries so that ownership of and capacity for an improved measurement agenda sits where the ability to act on evidence is greatest.
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